AMNEAL PHARMACEUTICALS, INC. Accounts Payable
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Accounts Payable of $266.36 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-06
- 2025-09-30: Accounts Payable, Current $266.36M.
- 2025-06-30: Accounts Payable, Current $205.81M.
- 2025-03-31: Accounts Payable, Current $192.53M.
- 2024-12-31: Accounts Payable, Current $258.69M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-09-30 | $266.36M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $205.81M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $192.53M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $258.69M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $235.00M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $199.58M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $175.32M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $143.57M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $177.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $139.53M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $136.92M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $165.98M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $131.08M 10-K · filed 2023-03-03 |
| 2020-12-31 | $153.14M 10-K · filed 2022-03-01 |
| 2019-12-31 | $103.02M 10-K · filed 2021-03-01 |
| 2018-12-31 | $114.85M 10-K · filed 2020-03-02 |
| 2018-09-30 | $124.54M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $169.05M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $70.01M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |